Ch50 Liposome Immunoassay: Your Trusted Immunoassay Solution from a Leading Manufacturer

Our company is proud to introduce our new cutting-edge technology - the Ch50 Liposome Immunoassay. This revolutionary diagnostic test offers superior accuracy and efficiency in detecting complement deficiencies, making it an indispensable tool in the field of clinical immunology. The Ch50 Liposome Immunoassay utilizes liposomes, which are nanoparticle-sized sacs composed of lipids that closely mimic cell membranes. These liposomes are loaded with a complement-activating solution and mixed with the patient's serum or plasma. The resulting mixture is then incubated to activate the complement system, which leads to the formation of a membrane attack complex (MAC). The MAC forms on the surface of the liposomes, causing them to release a fluorescent signal that is proportional to the level of complement activity. Compared to standard methodologies, the Ch50 Liposome Immunoassay offers several advantages. It is more sensitive, with a detection threshold as low as 0.01 U/ml. It is also more specific, as it detects only the classical and alternative complement pathways, avoiding interference from other proteins. The test is easy to perform, with a simple single-step incubation protocol and automated readout. Overall, the Ch50 Liposome Immunoassay is a powerful tool for diagnosing complement deficiencies, saving time and resources in the process. We are confident that our technology will provide valuable insights to healthcare providers and improve patient outcomes.